國際PNH興趣小組將PNH分為以下三類
經(jīng)典型PNH:該患者有典型的溶血和血栓形成;
合并其他骨髓衰竭性疾病:如再生性貧血(AA)或骨髓增生異常綜合征 (MDS);
亞臨床型PNH:患者有輕微的PNH克隆,但沒有溶血和血栓臨床證據(jù)。
品名 |
貨號 |
規(guī)格 |
品牌 |
FLAER(Alexa488 proaerolysin variant) solid format |
FL1-R |
25 ug |
Cedarlane |
FLAER(Alexa488 proaerolysin variant)liquid format |
FL1S-R |
25 ug |
Cedarlane |
FLAER(Alexa488 proaerolysin variant) solid format |
FL2-R |
50 ug |
Cedarlane |
FLAER(Alexa488 proaerolysin variant)liquid format |
FL2S-R |
50 ug |
Cedarlane |
Keeney M, Illingworth A,Sutherland DR ,etc. Paroxysmal Nocturnal Hemoglobinuria Assessment by FlowCytometric Analysis Clin Lab Med. 2017 Dec;37(4):855-867.
Sutherland DR, Kuek N, Azcona-Olivera J,etc. Use of a FLAER-based WBC assay in the primary screening of PNH clones. Am J Clin Pathol. 2009 Oct;132(4):564-72.
Illingworth AJ, Marinov I, Sutherland DR.Senstive andaccurate identification of PNH clones based on ICCS/ESCCA PNH ConsensusGuidelines-A summary. nt J Lab Hematol. 2019May;41